Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Positive topline results presented from pivotal phase III EMPOWUR study of vibegron

March 20, 2019

Arch Biopartners receives approval for phase I study of Metablok in Australia

March 20, 2019

Clinical data reported for litoxetine in mixed urinary incontinence

March 19, 2019

Veverimer phase III results for metabolic acidosis associated with chronic kidney disease

March 15, 2019

Dicerna enrolling in phase II study of DCR-PHXC for primary hyperoxaluria

March 11, 2019

Eli Lilly and Company synthesizes PDE1 inhibitors

March 4, 2019

Lilly synthesizes new phosphodiesterase PDE1 inhibitors

Feb. 26, 2019

Imarikiren improves albuminuria in patients with type 2 diabetes

Feb. 22, 2019

DDR1 inhibitor seen to prevent renal function loss in mice

Feb. 21, 2019

Positive data presented from phase II PHOENIX study of bardoxolone methyl

Feb. 21, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...